ArticleJournal of managed care & specialty pharmacy2015

A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes.

Keith B Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.